At a glance
- Originator Azwell
- Class Aniline compounds; Class I antiarrhythmics; Quinuclidines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 23 Jun 1995 Preclinical development for Arrhythmias in Japan (Unknown route)